SIGA Technologies, Inc. (SIGA)

Market Cap	325.27M -18.0%
Revenue (ttm)	94.57M -31.8%
Net Income	23.28M -60.7%
EPS	0.32 -61.0%
Shares Out	71.64M
PE Ratio	14.19
Forward PE	50.44
Dividend	$0.60 (13.22%)
Ex-Dividend Date	Apr 7, 2026

Volume	24,345
Open	4.570
Previous Close	4.580
Day's Range	4.570 - 4.590
52-Week Range	4.290 - 9.620
Beta	1.06
Analysts	n/a
Price Target	n/a
Earnings Date	May 7, 2026

About SIGA

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Sep 9, 1997
• Employees: 49
• Stock Exchange: NASDAQ
• Ticker Symbol: SIGA
• Website: https://www.siga.com

Financial Performance

In 2025, SIGA Technologies's revenue was $94.57 million, a decrease of -31.82% compared to the previous year's $138.72 million. Earnings were $23.28 million, a decrease of -60.69%.